Measuring Harms

Authored by: Jacob Stegenga

The Routledge Companion to Philosophy of Medicine

Print publication date:  October  2016
Online publication date:  October  2016

Print ISBN: 9781138846791
eBook ISBN: 9781315720739
Adobe ISBN: 9781317519850

10.4324/9781315720739.ch31

 Download Chapter

 

Abstract

The benefits and harms of pharmaceuticals are principal subjects of investigation in clinical science. In this chapter I discuss how harms are measured and note the challenges that clinical research faces in detecting harms of pharmaceuticals. This chapter provides an introduction to the structure of clinical research with a focus on harm detection. As it is usually performed today, clinical research does not reliably measure the harms of pharmaceuticals. There are at least three categories of problems with clinical research that lead to the underestimation of the harm profile of pharmaceuticals: subtle features of research methodology, secrecy surrounding the evidence from clinical research, and inadequate regulation.

 Cite
Search for more...
Back to top

Use of cookies on this website

We are using cookies to provide statistics that help us give you the best experience of our site. You can find out more in our Privacy Policy. By continuing to use the site you are agreeing to our use of cookies.